Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of ProKidney Corp (NASDAQ: PROK) was $2.14 for the day, down -2.28% from the previous closing price of $2.19. In other words, the price has decreased by -$2.28 from its previous closing price. On the day, 0.92 million shares were traded. PROK stock price reached its highest trading level at $2.25 during the session, while it also had its lowest trading level at $2.13.
Ratios:
Our analysis of PROK’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.32 and its Current Ratio is at 10.32.
On September 10, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $6.Guggenheim initiated its Buy rating on September 10, 2024, with a $6 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 13 ’25 when Pereira Brian JG sold 502,136 shares for $2.37 per share. The transaction valued at 1,190,062 led to the insider holds 0 shares of the business.
Pereira Brian JG sold 255,026 shares of PROK for $694,515 on Nov 12 ’25. The Director now owns 54,333 shares after completing the transaction at $2.72 per share. On Nov 12 ’25, another insider, Brian Pereira, who serves as the Director of the company, bought 675,234 shares for $2.70 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PROK now has a Market Capitalization of 643785600 and an Enterprise Value of 1361776256. For the stock, the TTM Price-to-Sale (P/S) ratio is 869.98. Its current Enterprise Value per Revenue stands at 1830.344 whereas that against EBITDA is -8.274.
Stock Price History:
The Beta on a monthly basis for PROK is 1.90, which has changed by 0.16489363 over the last 52 weeks, in comparison to a change of 0.09654534 over the same period for the S&P500. Over the past 52 weeks, PROK has reached a high of $7.13, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -23.28%, while the 200-Day Moving Average is calculated to be 15.41%.
Shares Statistics:
PROK traded an average of 1.99M shares per day over the past three months and 1500670 shares per day over the past ten days. A total of 135.98M shares are outstanding, with a floating share count of 103.33M. Insiders hold about 27.00% of the company’s shares, while institutions hold 28.52% stake in the company. Shares short for PROK as of 1761868800 were 12294628 with a Short Ratio of 6.19, compared to 1759190400 on 10707361. Therefore, it implies a Short% of Shares Outstanding of 12294628 and a Short% of Float of 12.629999999999999.
Earnings Estimates
. The current assessment of ProKidney Corp (PROK) involves the perspectives of 5.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.41 and -$1.07 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.65, with 5.0 analysts recommending between -$0.42 and -$1.2.
